The reduction of MACE with WEGOVY was not impacted by age, sex, race, ethnicity, BMI at baseline, or level of renal function impairment
Look for low-sugar or sugar-free electrolyte options
In April 2026, Canada became the first G7 country to approve a generic version of semaglutide for adults with type 2 diabetes
GLP-1 helps regulate appetite and blood sugar by: Reducing hunger signals in the brain Slowing gastric emptying Increasing feelings of fullness after meals Originally developed for type 2 diabetes, semaglutide was later shown at higher doses to produce significant, sustained weight loss
Patients taking insulin or sulfonylureas alongside Ozempic should monitor blood glucose levels carefully during periods of reduced food intake, as the risk of hypoglycaemia may increase